These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12685927)

  • 1. Country response to HIV/AIDS: national health accounts on HIV/AIDS in Brazil, Guatemala, Honduras, Mexico and Uruguay.
    Izazola-Licea JA; Avila-Figueroa C; Arán D; Piola S; Perdomo R; Hernandez P; Saavedra-Lopez JA; Valladares-Cardona R
    AIDS; 2002 Dec; 16 Suppl 3():S66-75. PubMed ID: 12685927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV/AIDS care and prevention expenditures in Mexico: trends and estimations 1997-2002].
    Magis-Rodríguez C; Rivera-Reyes Mdel P; Gasca-Pineda R; Gutiérrez JP
    Salud Publica Mex; 2005; 47(5):361-8. PubMed ID: 16323529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource requirements to fight HIV/AIDS in Latin America and the Caribbean.
    Opuni M; Bertozzi S; Bollinger L; Gutierrez JP; Massiah E; McGreevey W; Stover J
    AIDS; 2002 Dec; 16 Suppl 3():S58-65. PubMed ID: 12685926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2018 May; 391(10132):1799-1829. PubMed ID: 29678342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological transition in Latin America: a comparison of four countries].
    Albala C; Vio F; Yáñez M
    Rev Med Chil; 1997 Jun; 125(6):719-27. PubMed ID: 9580335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One world, one hope: the cost of providing antiretroviral therapy to all nations.
    Hogg RS; Weber AE; Craib KJ; Anis AH; O'Shaughnessy MV; Schechter MT; Montaner JS
    AIDS; 1998 Nov; 12(16):2203-9. PubMed ID: 9833862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the United Nations Declaration on HIV/AIDS resource targets].
    Teixeira L
    Rev Saude Publica; 2006 Apr; 40 Suppl():52-9. PubMed ID: 16729159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
    Gentilini M; Chieze F
    Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal care in Latin America].
    Buekens P; Hernández P; Infante C
    Salud Publica Mex; 1990; 32(6):673-84. PubMed ID: 2089644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS. Resource needs for HIV/AIDS.
    Schwartländer B; Stover J; Walker N; Bollinger L; Gutierrez JP; McGreevey W; Opuni M; Forsythe S; Kumaranayake L; Watts C; Bertozzi S
    Science; 2001 Jun; 292(5526):2434-6. PubMed ID: 11423619
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis on funds application of community based organizations involved in HIV/AIDS response and government financial investment in China, 2014].
    Zhang G; Zhu YX; Wang P; Liu P; Li JF; Sha S; Yang WZ; Li H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Mar; 51(3):232-236. PubMed ID: 28260337
    [No Abstract]   [Full Text] [Related]  

  • 12. Allocating HIV-prevention resources: balancing efficiency and equity.
    Kaplan EH; Merson MH
    Am J Public Health; 2002 Dec; 92(12):1905-7. PubMed ID: 12453805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financing the response to HIV in low-income and middle-income countries.
    Izazola-Licea JA; Wiegelmann J; Arán C; Guthrie T; De Lay P; Avila-Figueroa C
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S119-26. PubMed ID: 19901624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Private companies: an opportunity for hepatitis B virus (HBV) prevention and care in Ivory Coast in the wake of HIV/AIDS?].
    Bekelynck A
    Bull Soc Pathol Exot; 2015 Feb; 108(1):57-62. PubMed ID: 25407333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.
    Krentz HB; Auld MC; Gill MJ;
    CMAJ; 2003 Jul; 169(2):106-10. PubMed ID: 12874156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total HIV/AIDS expenditures in Dehong Prefecture, Yunnan province in 2010: the first systematic evaluation of both health and non-health related HIV/AIDS expenditures in China.
    Shan D; Sun J; Yakusik A; Chen Z; Yuan J; Li T; Fu J; Khoshnood K; Yang X; Wei M; Duan S; Bulterys M; Sante M; Ye R; Xiang L; Yang Y
    PLoS One; 2013; 8(6):e68006. PubMed ID: 23825694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Health Accounts development: lessons from Thailand.
    Tangcharoensathien V; Laixuthai A; Vasavit J; Tantigate NA; Prajuabmoh-Ruffolo W; Vimolkit D; Lertiendumrong J
    Health Policy Plan; 1999 Dec; 14(4):342-53. PubMed ID: 10787650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in healthcare expenditure among people living with HIV/AIDS in the United States: evidence from 10 Years of nationally representative data.
    Ritchwood TD; Bishu KG; Egede LE
    Int J Equity Health; 2017 Oct; 16(1):188. PubMed ID: 29078785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allocation analysis of central government AIDS special funding in priority sites of HIV/AIDS prevention and control].
    Wu D; Zhao Y; Liu H; Yin W; Zhang D; Li H; Hu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jun; 49(6):496-500. PubMed ID: 26310333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planning for the next generation.
    Valdes C
    People Planet; 1992; 1(3):24-5. PubMed ID: 12317703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.